REGEN – ARA-290 30mg, BPC-157 5mg, TB-500 (TB4) 5mg (40mg Blend)
$134.99
- ARA-290: 30mg
- BPC-157: 5mg
- TB-500 (TB4): 5mg
- Total Material: 40mg
- Vial Size: 3mL
- Three-component research formulation
- Molecular specifications supplied for each component
- Intended Use: Controlled laboratory research only
50 in stock
REGEN – ARA-290 30mg / BPC-157 5mg / TB-500 5mg – Powerful 40mg Research Blend
REGEN is a three-component research formulation containing ARA-290 30mg, BPC-157 5mg, and TB-500 (TB4) 5mg. Together, the individually listed quantities provide 40mg total specified research material in a 3mL vial.
The ARA 290 peptide component represents 30mg of the formulation, while BPC-157 and TB-500 each contribute 5mg. Each material has separately supplied molecular information for laboratory identification and research documentation.
ARA 290 Peptide REGEN Research Overview
The supplied REGEN formulation contains:
| Specification | ARA-290 | BPC-157 | TB-500 (TB4) |
|---|---|---|---|
| Quantity | 30mg | 5mg | 5mg |
| Molecular Formula | C51H84N16O21 | C62H98N16O22 | C212H350N56O78S |
| Molecular Weight | 1257.3 g/mol | 1419.556 g/mol | 4963 g/mol |
| Supplied PubChem CID | 91810664* | 9941957 | 16132341 |
| CAS Number | 1208243-50-8 | 137525-51-0 | 77591-33-4 |
Total Material: 40mg
Vial Size: 3mL
*The supplied ARA-290 PubChem CID is 91810664, but the provided PubChem hyperlink points to compound 9941957. This discrepancy should be verified before using that external record as confirmation of the ARA-290 identifier.
ARA-290 30mg Molecular Specifications
The primary component of REGEN is ARA-290 30mg.
The supplied sequence is:
PyroGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
The alternative notation supplied is:
pGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser
Its supplied molecular formula is:
C51H84N16O21
The molecular weight is 1257.3 g/mol, while the supplied CAS number is 1208243-50-8.
The provided PubChem CID is 91810664. However, the URL supplied alongside that identifier points to compound 9941957 rather than 91810664. The identifier and link should therefore be verified before publication rather than silently reconciled.
ARA 290 Peptide Research Identification
The ARA 290 peptide component can be documented using its supplied sequence, molecular formula, molecular weight, CAS number, and stated database identifier.
For laboratory records, these characteristics provide more precise identification than relying solely on the REGEN product name or variations in keyword formatting.
Researchers comparing external records should confirm that the molecular identity being investigated corresponds to the specifications of the actual material.
BPC-157 5mg Specifications
The second component contains 5mg BPC-157.
Its supplied sequence is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
The molecular formula is:
C62H98N16O22
The supplied molecular weight is 1419.556 g/mol, PubChem CID is 9941957, and CAS number is 137525-51-0.
Researchers can examine records associated with this formula using the PubChem molecular formula search for C62H98N16O22.
These specifications provide multiple reference points for research documentation.
TB-500 5mg Specifications
The third component contains 5mg TB-500 (TB4).
Its supplied sequence is:
Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH
Its molecular formula is:
C212H350N56O78S
The supplied molecular weight is 4963 g/mol, PubChem CID is 16132341, and CAS number is 77591-33-4.
Researchers can investigate records associated with this formula through the PubChem molecular formula search for C212H350N56O78S.
REGEN 40mg Three-Component Research Formulation
REGEN contains three individually specified materials:
ARA-290: 30mg
BPC-157: 5mg
TB-500 (TB4): 5mg
Together, the quantities provide 40mg total specified research material.
The complete combination should be distinguished from experiments examining ARA-290, BPC-157, or TB-500 independently. Findings involving an isolated component should not automatically be generalized to this three-component formulation.
ARA 290 and ARA-290 Search Terminology
Researchers may encounter both ara 290 and ara-290 when searching scientific databases and other resources.
These formatting variations do not replace molecular identification.
For this product, the supplied ARA-290 specifications include a defined sequence, C51H84N16O21 formula, 1257.3 g/mol molecular weight, CAS 1208243-50-8, and supplied PubChem CID 91810664.
Using these characteristics can provide more precise research documentation than relying on keyword formatting alone.
ARA 290 Peptides and Research Context
Searches for ara 290 peptides may reflect broader research interest surrounding this material.
Within REGEN, ARA-290 is one of three specified components and accounts for 30mg of the total 40mg material.
Controlled investigation of the complete formulation may require documentation of variables such as:
- Identity of all three components
- Individual material quantities
- Molecular characteristics
- Experimental concentration
- Research model
- Appropriate controls
- Exposure conditions
- Analytical methodology
- Observation period
- Experimental endpoints
- Reproducibility
Results should remain associated with the exact experimental conditions under which they were generated.
3mL Research Vial
The complete REGEN formulation is supplied in a 3mL vial.
Vial capacity is a physical product specification. It does not independently determine final preparation volume, experimental concentration, or administration quantity.
No solvent, reconstitution procedure, storage condition, or experimental concentration was included in the supplied information.
Those details are therefore not being inferred.
Laboratory Research Documentation
Research records for REGEN can include:
ARA-290: 30mg
BPC-157: 5mg
TB-500 (TB4): 5mg
Total Material: 40mg
Vial Capacity: 3mL
Component-level documentation can additionally include each supplied sequence, molecular formula, molecular weight, PubChem identifier, and CAS number.
Experiment-specific records may document concentration, research model, controls, methodology, exposure conditions, analytical procedures, and measured endpoints.
Evaluating Scientific Literature
When evaluating publications concerning an ARA 290 peptide or either of the other components, researchers should determine whether the study investigates an isolated material or a multi-component formulation.
Relevant comparison factors include:
- Exact molecular identity
- Individual components
- Material quantities
- Experimental concentration
- Research model
- Study design
- Controls
- Analytical methodology
- Exposure conditions
- Measured endpoints
Research concerning an individual component should not automatically be interpreted as evidence concerning the complete REGEN formulation.
Related OROS Research Materials
Researchers can explore 5-Amino-1MQ 50mg as a separately specified research material.
Another multi-component formulation is AEGIS – BPC-157 / TB-500 / KPV.
Researchers can also review AHK-Cu 100mg and AOD-9604 5mg as separately specified catalog materials.
Each product has its own specifications and should be evaluated independently.
Scientific Research Resources
Researchers can use PubChem to investigate molecular records, formulas, and available chemical identifiers.
Peer-reviewed biomedical and experimental literature can be searched through PubMed.
Researchers should verify the exact molecular identity, research model, experimental concentration, methodology, controls, and endpoints before comparing findings across studies.
Research FAQ
What is REGEN?
REGEN is the product designation used here for a three-component research blend containing ARA-290 30mg, BPC-157 5mg, and TB-500 5mg.
What is the ARA 290 peptide quantity?
The formulation contains 30mg ARA-290.
What is the supplied ARA-290 sequence?
The supplied sequence is PyroGlu-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser, also supplied in the abbreviated form beginning with pGlu.
What is the molecular formula of ARA-290?
The supplied molecular formula is C51H84N16O21.
What is the PubChem CID for ARA-290?
The supplied value is 91810664. However, the hyperlink supplied with that value points to PubChem compound 9941957, so the identifier/link combination should be verified before publication.
How much BPC-157 and TB-500 does REGEN contain?
The formulation contains 5mg BPC-157 and 5mg TB-500 (TB4).
How much total research material is supplied?
The three listed components provide 40mg total specified material.
What size vial is supplied?
REGEN is supplied in a 3mL vial.
Research Use Disclaimer
This REGEN ARA 290 peptide / BPC-157 / TB-500 formulation is presented exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. Material quantities and vial capacity are research specifications and do not constitute human dosing or administration guidance. This information does not provide instructions for injection, self-administration, therapeutic use, diagnosis, treatment, athletic performance enhancement, bodybuilding, or veterinary application.
| Net Weight |
40mg |
|---|---|
| Brand |
OROS Research |
| Format |
Lyophilized Vial |

Reviews
There are no reviews yet.